Showing results (841-850 of 1,074) with videos related to
Sort By:
Pageof 108
Therapeutic Advances in Neurological Disorders|June 9, 2025
Decoding crosstalk between neurotransmitters and α-synuclein in Parkinson's disease: pathogenesis and therapeutic implicationsLihua Guan, Liling Lin, Chaochao Ma, et al.Therapeutic Advances in Neurological Disorders|June 10, 2025
Measuring incremental burdens associated with increasing preventive-treatment failures among adults with migraine: a retrospective, cross-sectional studyJessica Ailani, Nemin Chen, Avani Patel, et al.Therapeutic Advances in Neurological Disorders|August 22, 2025
Orthostatic hypotension in Parkinson's disease: therapeutic considerationsKara J Wyant, Vikas KotagalTherapeutic Advances in Neurological Disorders|February 2, 2026
Objective tremor monitoring using tri-axis accelerometer in MRgFUS thalamotomy for essential tremor: a feasibility studyKai-Chun Liu, Antonella Macerollo, Hoon-Ming Heng, et al.Therapeutic Advances in Neurological Disorders|February 3, 2026
Efficacy and safety of glucagon-like peptide-1 receptor agonists in Parkinson's disease: a systematic review and meta-analysis of randomized placebo-controlled clinical trialsMaria-Ioanna Stefanou, Evangelos Panagiotopoulos, Anastasios Tentolouris, et al.Therapeutic Advances in Neurological Disorders|January 26, 2026
Efgartigimod as a treatment for people with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): a plain language summary of publication of the ADHERE trialJeffrey A Allen, Luis Querol, Niraja Suresh, et al.Therapeutic Advances in Neurological Disorders|January 15, 2026
Heart rate and clinical outcome after endovascular treatment in patients with anterior versus posterior circulation large vessel occlusionLu Zhang, Ying-Jia Wang, Hui-Sheng ChenTherapeutic Advances in Neurological Disorders|March 18, 2025
Evaluating natalizumab first-line and later-line use in multiple sclerosis: a US claims database analysisRobin L Avila, Nicole S Croteau, Fei Tang, et al.Therapeutic Advances in Neurological Disorders|March 17, 2025
Immunotherapy-mediated modulation of the gut microbiota in multiple sclerosis and associations with diet and clinical response-the effect of dimethyl fumarate therapyElsebeth Staun-Ram, Anat Volkowich, Ariel MillerTherapeutic Advances in Neurological Disorders|July 17, 2013
The balance and gait disorder of essential tremor: what does this mean for patients?David Arkadir, Elan D LouisPageof 108